These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25762782)

  • 1. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
    Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
    J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
    Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
    PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination.
    Mc Guire C; Wieghofer P; Elton L; Muylaert D; Prinz M; Beyaert R; van Loo G
    J Immunol; 2013 Mar; 190(6):2896-903. PubMed ID: 23401595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
    Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
    Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
    Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
    EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
    Brüstle A; Brenner D; Knobbe CB; Lang PA; Virtanen C; Hershenfield BM; Reardon C; Lacher SM; Ruland J; Ohashi PS; Mak TW
    J Clin Invest; 2012 Dec; 122(12):4698-709. PubMed ID: 23114599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
    Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
    Front Immunol; 2019; 10():1898. PubMed ID: 31474984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T Cells.
    Rieder SA; Metidji A; Glass DD; Thornton AM; Ikeda T; Morgan BA; Shevach EM
    J Immunol; 2015 Jul; 195(2):553-63. PubMed ID: 26062998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
    Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
    Front Immunol; 2020; 11():576651. PubMed ID: 33042160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.
    Martin K; Touil R; Kolb Y; Cvijetic G; Murakami K; Israel L; Duraes F; Buffet D; Glück A; Niwa S; Bigaud M; Junt T; Zamurovic N; Smith P; McCoy KD; Ohashi PS; Bornancin F; Calzascia T
    J Immunol; 2019 Dec; 203(11):2791-2806. PubMed ID: 31659015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
    Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
    J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
    Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
    J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation.
    Deason K; Troutman TD; Jain A; Challa DK; Mandraju R; Brewer T; Ward ES; Pasare C
    J Exp Med; 2018 Sep; 215(9):2413-2428. PubMed ID: 30093533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
    Bjarnadóttir K; Benkhoucha M; Merkler D; Weber MS; Payne NL; Bernard CCA; Molnarfi N; Lalive PH
    Sci Rep; 2016 Oct; 6():34594. PubMed ID: 27708418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.